The objective of the Novo Nordisk Foundation is to provide a stable basis for the commercial and research activities of Novo Nordisk and support scientific, humanitarian and social purposes.
The Foundation may in connection with a capital increase in Novo Nordisk or a merger of Novo Nordisk with other companies waive its controlling interest in Novo Nordisk if it is necessary to uphold and develop the commercial and research activities of Novo Nordisk as an internationally competitive business. However, the Foundation shall strive to maintain material influence in Novo Nordisk through Novo Holdings A/S.
The Foundation wishes to be an “Engaged Owner” in relation to Novo Nordisk and apply engaged ownership objectives and principles which among other things are described in ‘Objectives & Principles for engaged ownership in relation to Novo Nordisk A/S and Novozymes A/S’, cf. www.novonordiskfonden.com. The Foundation supports Novo Nordisk in achieving its vision, ensuring competitive financial results and adhering to the Charter for Companies in the Novo Group. All strategic and operational matters are solely decided by the Board and the Executive Management of Novo Nordisk.